Powder: -20°C for 3 years | In solvent: -80°C for 1 year
UBE2T/FANCL-IN-1 is a highly effective inhibitor of UBE2T/FANCL-mediated FANCD2 monoubiquitylation. It greatly enhances the sensitivity of cells to Carboplatin, a DNA cross-linking agent.
Description | UBE2T/FANCL-IN-1 is a highly effective inhibitor of UBE2T/FANCL-mediated FANCD2 monoubiquitylation. It greatly enhances the sensitivity of cells to Carboplatin, a DNA cross-linking agent. |
In vitro | UBE2T/FANCL-IN-1 (CU2) effectively prevents GST-FANCLRING ubiquitylation at a concentration of 100 μM. At a higher dosage of 500 μM, it significantly reduces the ubiquitylation of FANCD2 mediated by HU and Cisplatin (10 μM) treatments over timespans of 6, 12, and 24 hours. Furthermore, using 250 μM of UBE2T/FANCL-IN-1 in combination with 15 μM carboplatin markedly inhibits cell proliferation, resulting in less than 50% confluence after 8 days[1]. |
Synonyms | UBE2T/FANCL-IN-1 |
Molecular Weight | 357.506 |
Formula | C19H31N7 |
CAS No. | 1359415-02-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
UBE2T/FANCL-IN-1 1359415-02-3 UBE-2T/FANCL-IN-1 UBE2T/FANCLIN1 UBE2T/FANCL IN 1 inhibitor inhibit